Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Pfeiffer

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Arthritis Research & Therapy|November 24, 2022
Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registryNorbert Blank, Marc Schmalzing, Pia Moinzadeh, et al.
Nature Genetics|July 31, 2007
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosusMin Ae Lee-Kirsch, Maolian Gong, Dipanjan Chowdhury, et al.
Rheumatology (Oxford, England)|January 28, 2023
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic SclerosisMichael Kreuter, Francesco Bonella, Norbert Blank, et al.
Frontiers in Oncology|October 8, 2021
Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic MelanomaJan-Malte Placke, Camille Soun, Jenny Bottek, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionMarkus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.
Chest|August 15, 2023
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic SclerosisPia Moinzadeh, Francesco Bonella, Max Oberste, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5<sup>+</sup> mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisPia Moinzadeh, Elisabeth Aberer, Keihan Ahmadi-Simab, et al.
The Journal of Rheumatology|November 17, 2015
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsPia Moinzadeh, Gabriela Riemekasten, Elise Siegert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departmentsNina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Arthritis Research & Therapy|November 24, 2022
Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registryNorbert Blank, Marc Schmalzing, Pia Moinzadeh, et al.
Nature Genetics|July 31, 2007
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosusMin Ae Lee-Kirsch, Maolian Gong, Dipanjan Chowdhury, et al.
Rheumatology (Oxford, England)|January 28, 2023
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic SclerosisMichael Kreuter, Francesco Bonella, Norbert Blank, et al.
Frontiers in Oncology|October 8, 2021
Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic MelanomaJan-Malte Placke, Camille Soun, Jenny Bottek, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionMarkus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.
Chest|August 15, 2023
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic SclerosisPia Moinzadeh, Francesco Bonella, Max Oberste, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 6, 2021
Allogeneic ABCB5<sup>+</sup> mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trialAndreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Annals of the Rheumatic Diseases|January 7, 2014
Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisPia Moinzadeh, Elisabeth Aberer, Keihan Ahmadi-Simab, et al.
The Journal of Rheumatology|November 17, 2015
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsPia Moinzadeh, Gabriela Riemekasten, Elise Siegert, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 7, 2012
Diagnostics of autoimmune bullous diseases in German dermatology departmentsNina van Beek, Diana Knuth-Rehr, Peter Altmeyer, et al.
Pageof 4